Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Vicki Doctor
Observed name:
V. Doctor
Institutions:
Cancer Treatment Centers of America,
City of Hope
Observed institutions:
City Of Hope National Medical Center,
Cancer Treatment Centers of America,
Midwestern Regional Medical Center,
City of Hope,
Foundation Medicine (United States)
ORCID:
0000-0003-3028-7404
Observed ORCID:
0000-0003-3028-7404
OpenAlex ID:
A5046832911
Racial differences in the mutational landscape of serous endometrial cancer.
2022
·
Julian C. Schink
, Ruchi Garg
, et al.
·
Journal of Clinical Oncology
·
4
Mutational landscape of pancreatic adenocarcinoma identified by prospective clinical sequencing in a nationwide cancer network.
2022
·
Katherine E Poruk
, Amber Moran
, et al.
·
Journal of Clinical Oncology
·
2
36 Mutational landscape of low-grade serous carcinoma of the ovary
2022
·
Julian Schink
, Ruchi Garg
, et al.
·
Gynecologic Oncology Reports
·
1
PDF
Treatment of Patients With Lobular Breast Cancer Harboring Human Epidermal Growth Factor Receptor 2 Mutation With HER2-Directed Therapy
2018
·
Dennis L. Citrin
, Bradford A. Tan
, et al.
·
JCO Precision Oncology
·
1
Assessing Genomic Literacy and Education in Community Oncology Settings
2026
·
Vicki Doctor
, Leighsa Sharoff
, et al.
·
Oncology Issues
PDF
Overlayed heatmap images of all the locations of brain lesions at the time of diagnosis, with the white color indicating no overlap and the red color indicating overlap with at least one other patient.
2026
·
Amanda Reyes
, Isa Mambetsariev
, et al.
·
ASVIDE
Overlayed heatmap images of all the locations of brain lesions at the time of progression in the brain, with the white color indicating no overlap and the red color indicating overlap with at least one other patient.
2026
·
Amanda Reyes
, Isa Mambetsariev
, et al.
·
ASVIDE
The IMMUNO-BIOMAP trial in NSCLC: An adaptive multimodal framework for biomarker-guided care
2026
·
Aritro Nath
, Jyoti Malhotra
, et al.
·
Cell Reports Medicine
Use of ALK Inhibitors in Patients With Nonlung Malignancies Bearing ALK Alteration Prolongs Treatment Duration
2026
·
Vitor Abreu de Góes
, Matthew Lee
, et al.
·
JCO Precision Oncology
Patterns of central nervous system disease and molecular landscape in epidermal growth factor receptor exon 20 insertion mutated non-small cell carcinoma
2026
·
Amanda Reyes
, Isa Mambetsariev
, et al.
·
Translational Lung Cancer Research
Abstract 3911: Use of ALK inhibitors in patients with non-lung malignancies bearing ALK alteration prolongs treatment duration.
2026
·
Vitor Abreu de Goes
, Miguel Zugman
, et al.
·
Cancer Research
Long-term survival of patients with lung cancer with kinase fusions (KF) treated at a tertiary community-based cancer program.
2024
·
Vicki Doctor
, Bradford A. Tan
, et al.
·
Journal of Clinical Oncology
Medication acquisition program: Successful access to innovative treatment options.
2023
·
Vicki Doctor
, Julian C. Schink
, et al.
·
Journal of Clinical Oncology
Impact of clinical and genomic factors on outcomes for pancreatic adeoncarcinoma based on race
2023
·
K.E. Poruk
, A. Moran
, et al.
·
HPB
PDF
37 Therapeutic implications of mutations in high grade serous ovarian carcinoma when evaluated by race
2022
·
Ruchi Garg
, Julian Schink
, et al.
·
Gynecologic Oncology Reports
PDF
6 Racial differences in the mutational landscape of serous endometrial cancer
2022
·
Ruchi Garg
, Julian Schink
, et al.
·
Gynecologic Oncology Reports
PDF
Outcomes of Early-Stage Pancreatic Adenocarcinoma Based on Clinical Factors and Genomic Mutations
2022
·
Katherine E Poruk
, Amber Moran
, et al.
·
Journal of the American College of Surgeons
Therapeutic implications of mutations in high grade serous ovarian carcinoma when evaluated by race.
2022
·
Ruchi Garg
, Julian C. Schink
, et al.
·
Journal of Clinical Oncology
Evaluation of stage IV pancreatic adenocarcinomas based on mutational profiling of tumors.
2022
·
Katherine E Poruk
, Amber Moran
, et al.
·
Journal of Clinical Oncology
Mutational landscape of low-grade serous carcinoma of the ovary.
2022
·
Julian C. Schink
, Ruchi Garg
, et al.
·
Journal of Clinical Oncology
Evaluation of pathologic and genomic characteristics in female breast cancer patients.
2021
·
Damien Mikael Hansra
, Amber Moran
, et al.
·
Journal of Clinical Oncology
A medication acquisition program to facilitate access to nonstandard targeted oncologic therapies.
2021
·
Vicki Doctor
, Maurie Markman
, et al.
·
Journal of Clinical Oncology
Genomic testing for HER2 mutation in patients with metastatic lobular carcinoma of the breast.
2018
·
Dennis L. Citrin
, Arun Kadamkulam Syriac
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
23
Citation count:
8
H-index:
2
I10-index:
Year
Topic
Type